Starion Instruments Signs Distribution Agreement With Datascope for Tissue Welding...

Starion Instruments Signs Distribution Agreement With Datascope for Tissue
Welding Technology
Agreement Reinforces Starion's Leadership Position in the Cardiac Marketplace

SUNNYVALE, Calif., July 22 /PRNewswire/ -- Starion Instruments, a leading
surgical device company, today announced a non-exclusive distribution
agreement with Datascope Corp. to integrate Starion's patented Tissue Welding
technology into Datascope's procedural kits for endoscopic saphenous vein and
radial artery harvesting.
The driving force behind this new agreement was Datascope's customer
demand for Starion's Tissue Welding technology, which uses direct heat and
pressure to simultaneously seal and divide soft tissue and vessels, reducing
the risk of inadvertent collateral damage. Datascope customers now have
access to Starion's STLS 23 and STLS 35 Thermal Ligating Shears for
unparalleled effectiveness, reliability and versatility during endoscopic
cardiac procedures.
Dr. Antonino Laudani, chief operating officer of Datascope, said, "We are
continuously looking for opportunities to meet customer needs in the
cardiovascular market. Starion's distribution agreement allows us to broaden
our endoscopic vessel harvesting range, and therefore contributes to our
global growth strategy."
"Demand for our products is growing as surgeons and patients experience
the clinical benefits of Tissue Welding technology over traditional seal and
cut modalities," said Kirt Kirtland, president and chief executive officer of
Starion Instruments. "This new agreement reflects this increased demand and
enables us to strengthen our leadership position in the cardiac marketplace."
About Starion Instruments
Starion develops advanced surgical devices that enhance performance,
minimize risk and improve patient outcomes. Starion's instruments employ a
patented Tissue Welding technology that seals and divides soft tissue with
only focused heat and pressure. Known for their effectiveness, reliability
and versatility, Starion's products are used worldwide for open and endoscopic
cardiac, gynecology, general surgery, otolaryngology and urology procedures.
For more information, visit http://www.starioninstruments.com.
About Datascope Corp.
Datascope Corp. is the global leader of intra-aortic balloon
counterpulsation and a diversified medical device company that develops,
manufactures and markets proprietary products for clinical health care markets
in interventional cardiology and radiology, cardiovascular and vascular
surgery, and critical care. The Company's products are sold throughout the
world through direct sales representatives and independent distributors.
Founded in 1964, Datascope is headquartered in Montvale, New Jersey. For news
releases, webcasts and other Company information please visit Datascope's
website, http://www.datascope.com.
SOURCE Starion Instruments

Melissa Valdez of Starion Instruments, +1-408-522-5200,
mvaldez@starioninstruments.com